Dr. Jackson Glenn Turbeville, MD

Dr. Turbeville practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Turbeville's NPI, 1790217768, was assigned on March 29, 2017. Dr. Turbeville graduated from University of South Carolina School of Medicine, Greenville in 2017. Dr. Turbeville holds Wisconsin license 22880.

Dr. Turbeville's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Turbeville's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Turbeville is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Dr. Turbeville to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Turbeville's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Turbeville practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Turbeville's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Turbeville's licenses on file in 3 states: Wisconsin, Florida and Minnesota.

CMS data shows 941 Medicare services from Dr. Turbeville across 13 procedure codes in 2024, for 320 Medicare patients. Medicare paid $28,545 for them.

CMS counts 320 Medicare patients who saw Dr. Turbeville in 2024. The largest group is 65 to 74, with 162 patients. 68% of them have high cholesterol, and 65% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Turbeville's median patient age at 34, with 52% women.

In 2024, Dr. Turbeville wrote 280 Medicare Part D claims for 103 patients. 89% of them were for generic drugs. CMS names the drug for 142 of them, across 6 drugs with 11 or more claims each, at $7,727 in total drug cost. In 2023, CMS named 88 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Turbeville for performance year 2024, reported as part of a group. Dr. Turbeville accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of melanoma (skin cancer) excision by Dr. Turbeville, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Turbeville, published from 2017 to 2025. 2022 was the busiest year, with 2. The most frequent topics are Skin Neoplasms. Dr. Turbeville has published most often in Pediatr Dermatol. Dr. Turbeville's most frequent co-authors are Aderonke Olufikayo Adekunle-Ojo, MD, Kenneth D. Aldape, MD and Olabola Awosika, MD.

CMS Open Payments shows 13 general payments to Dr. Turbeville from 8 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 83% of the total. Janssen Pharmaceuticals, Inc paid the most, $505.

Dr. Turbeville graduated from University of South Carolina School of Medicine, Greenville in 2017.